ONASSIST is a registry of coronary ill patients who have had a functional test measuring anti-platelet effect and/or a genetic profile of response to anti-platelet drugs.
The Onassist Project is an assistance for cardiologists that establishes an individual risk of stent thrombosis for each patient based on: * a functional approach (evaluation of the antiplatelet effect of the antiplatelet regimen by multiple tests) and * a pharmacogenomic approach (genetic profile of response to antiplatelet agents) It provides advices for specific therapeutics after identification of adverse drug interactions, treatment compliance issues and true genetic, functional or mixed resistance. This individualized strategy allow to adjust the choice of the drugs and their optimal dosage considering the best benefit - risk ratio. Follow up are regularly made to identify markers of MACE (major adverse cardiac event) or bleeding.
Study Type
OBSERVATIONAL
Enrollment
5,000
Hopital Pitie Salpetriere
Paris, France
RECRUITINGBleeding
all bleeding according to the BARC (Bleeding Academic Research Consortium) definitions are registered during the follow up
Time frame: 10 years
Myocardial Infarction
Time frame: 10 years
Death
Time frame: 10 years
Stroke
Time frame: 10 years
Urgent Revascularization
Time frame: 10 years
Resuscitated Cardiac Arrest
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.